Study details
Enrolling now
Skin-interfaced Colorimetric Bifluidic Sweat Sensor Device for the Diagnosis of Cystic Fibrosis (CF)
Milton S. Hershey Medical Center
NCT IDNCT05998629ClinicalTrials.gov data as of Apr 2026
Target enrollment
30
Study length
about 1.4 years
Ages
18–80
Locations
1 site in PA
What this study is about
This trial is testing a new device to diagnose cystic fibrosis (CF). The device measures sweat chloride levels using two channels. This single-center trial will enroll 30 participants, including adults with CF or healthy volunteers, and it will compare the device's measurements to standard lab tests.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Undergo Standard of Care laboratory procedure for measurement of sweat
- 2.Use a skin-interfaced colorimetric bifluidic sweat device with two synchronous channels
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Respiratory